Xử trí hội chứng vành cấp ở người có bệnh thận mạn

41 145 0
Xử trí hội chứng vành cấp ở người có bệnh thận mạn

Đang tải... (xem toàn văn)

Tài liệu hạn chế xem trước, để xem đầy đủ mời bạn chọn Tải xuống

Thông tin tài liệu

Management of Acute Coronary Syndrome in Chronic Kidney Disease Dafsah Arifa Juzar Indonesian Heart Association Harapan Kita, Jakarta, Indonesian • • • • • • Background Diagnostic Reperfusion Antiplatelets & Anticoagulant Betablocker RAAS inhibitor Background • The incidence of AMI is increased in this vulnerable subgroup • Atypical clinical presentation of AMI may be more frequent • ECG changes that may mimic or obscure AMI • Left ventricular hypertrophy is common • patients with renal dysfunction are more prone to adverse events • Cardiovasscular medication : antiplatelets & anticoagulation, • Cardiovascular procedures : coronary • Relative lack of evidence and potential for uncertainty in selecting medications Clinical Presentation of ACS Among CKD Patients Szummer K et al J Intern Med 2010;268:40–49 Unique pathobiology of CKD • greater luminal encroachment and • higher plaque burden • greater necrotic core and dense calcium with less fibrous tissue • modulate coronary atherosclerotic plaque composition to a less stable phenotype – Metalloproteinases are elevated – potentiates foam cell generation by enhancing macrophage entry • accelerated infarct expansion in association with enhanced inflammation and oxidative stress, Baber U, etal JACC Cardiovasc Imaging 2012;5:S53–S61 Ponda MP etal Atherosclerosis 2010;210:57–62 Naito K, Anzai, etal J Card Fail 2008; Pelisek J, etal P J Vasc Surg 2011 Prone to adverse event Gibson CM, etal Eur Heart J 2004;25:1998–2005 Age adjusted Hazard Ratio for death from any cause CV event & Hospitalization 1,200,295 ambulatory adults Go AS et al N Engl J Med 2004;351:1296–1305 Conservative (C) VS Invasive (I) protocol defined bleeding TACTIC TIMI IB Januzzi J, etal Am J Cardiol 2002 Dec 1;90(11):1246-9 Relevance CKD in ACS • underutilization of known cardio-protective therapies, • less aggressive treatment, • more frequent errors in dosing with excess toxicity from conventional therapies Diagnostic Cardiac biomarker Anticoagulant • Patients with CrCl

Ngày đăng: 05/12/2017, 00:51

Từ khóa liên quan

Tài liệu cùng người dùng

Tài liệu liên quan